Private Health Insurance Coverage of Drug Use Disorder Treatment: 2005-2018

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Oct 9

PMID 33035265

Citations 3

Authors

Ramin Mojtabai

Christine Mauro

Melanie M Wall

Colleen L Barry

Mark Olfson

Affiliations

Soon will be listed here.

Abstract

Many privately insured adults with drug use disorders in the United States do not have health care coverage for drug use treatment. The Affordable Care Act sought to redress this gap by including substance use treatments as essential health benefits under new plans offered. This study used data from 11,732 privately insured adult participants of the 2005-2018 National Survey on Drug Use and Health with drug use disorders to examine trends in drug use treatment coverage and the association of coverage with receiving treatment. 37.6% of the participants with drug use disorders did not know whether their plan covered drug use treatment, with little change over time. Among those who knew, coverage increased modestly between the 2005-2013 and 2014-2018 periods (73.5% vs. 77.5%, respectively, p = .015). Coverage was associated with receiving drug use treatment (adjusted odds ratio = 2.09, 95% confidence interval = 1.61-2.72, p < .001). However, even among participants with coverage, only 13.4% received treatment. Broader coverage of drug use treatment could potentially improve treatment rates.

Citing Articles

Tieu L, Pourat N, Bromley E, Simhan R, Bastani R, Glenn B Subst Use. 2024; 18:29768357241301990.

PMID: 39588291 PMC: 11587183. DOI: 10.1177/29768357241301990.

Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids.

Miller E, DeVeaugh-Geiss A, Chilcoat H Drug Alcohol Depend Rep. 2024; 10:100220.

PMID: 38414666 PMC: 10897812. DOI: 10.1016/j.dadr.2024.100220.

Associations between lifetime mental disorders and suicidal behaviors: findings from the Taiwan psychiatry morbidity survey.

Shan J, Chen I, Lin P, Chen W, Liao S, Lee M Soc Psychiatry Psychiatr Epidemiol. 2022; 57(8):1579-1589.

PMID: 35150308 DOI: 10.1007/s00127-022-02236-8.

References

Busch S, Epstein A, Harhay M, Fiellin D, Un H, Leader Jr D . The effects of federal parity on substance use disorder treatment. Am J Manag Care. 2014; 20(1):76-82. PMC: 3987861. View

Barry C, Goldman H, Huskamp H . Federal Parity In The Evolving Mental Health And Addiction Care Landscape. Health Aff (Millwood). 2016; 35(6):1009-16. DOI: 10.1377/hlthaff.2015.1653. View

Saloner B, Maclean J . Specialty Substance Use Disorder Treatment Admissions Steadily Increased In The Four Years After Medicaid Expansion. Health Aff (Millwood). 2020; 39(3):453-461. PMC: 7853763. DOI: 10.1377/hlthaff.2019.01428. View

Sawyer A, Kwitowski M, Benotsch E . Are You Covered? Associations Between Patient Protection and Affordable Care Act Knowledge and Preventive Reproductive Service Use. Am J Health Promot. 2017; 32(4):906-915. DOI: 10.1177/0890117117736091. View

Freyer J, Tonigan J, Keller S, John U, Rumpf H, Hapke U . Readiness to change versus readiness to seek help for alcohol problems: the development of the Treatment Readiness Tool (TReaT). J Stud Alcohol. 2005; 65(6):801-9. DOI: 10.15288/jsa.2004.65.801. View

Buck J . The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff (Millwood). 2011; 30(8):1402-10. DOI: 10.1377/hlthaff.2011.0480. View

Grant B, Saha T, Ruan W, Goldstein R, Chou S, Jung J . Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry. 2015; 73(1):39-47. PMC: 5062605. DOI: 10.1001/jamapsychiatry.2015.2132. View

Hadley J, Holahan J . Is health care spending higher under Medicaid or private insurance?. Inquiry. 2004; 40(4):323-42. DOI: 10.5034/inquiryjrnl_40.4.323. View

Maclean J, Saloner B . The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act. J Policy Anal Manage. 2019; 38(2):366-93. PMC: 7071834. View

10.

Reif S, Creedon T, Horgan C, Stewart M, Garnick D . Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014. J Psychoactive Drugs. 2017; 49(2):102-110. PMC: 5861719. DOI: 10.1080/02791072.2017.1300360. View

11.

Wells K, Klap R, Koike A, Sherbourne C . Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. Am J Psychiatry. 2001; 158(12):2027-32. DOI: 10.1176/appi.ajp.158.12.2027. View

12.

Saloner B, Levin J, Chang H, Jones C, Alexander G . Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion. JAMA Netw Open. 2019; 1(4):e181588. PMC: 6324520. DOI: 10.1001/jamanetworkopen.2018.1588. View

13.

Grogan C, Andrews C, Abraham A, Humphreys K, Pollack H, Smith B . Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health Aff (Millwood). 2016; 35(12):2289-2296. PMC: 5304419. DOI: 10.1377/hlthaff.2016.0623. View

14.

Perron B, Mowbray O, Glass J, Delva J, Vaughn M, Howard M . Differences in service utilization and barriers among Blacks, Hispanics, and Whites with drug use disorders. Subst Abuse Treat Prev Policy. 2009; 4:3. PMC: 2660316. DOI: 10.1186/1747-597X-4-3. View

15.

Han B, Gfroerer J, Kuramoto S, Ali M, Woodward A, Teich J . Medicaid Expansion Under the Affordable Care Act: Potential Changes in Receipt of Mental Health Treatment Among Low-Income Nonelderly Adults With Serious Mental Illness. Am J Public Health. 2015; 105(10):1982-9. PMC: 4566525. DOI: 10.2105/AJPH.2014.302521. View

16.

Frank R, Beronio K, Glied S . Behavioral health parity and the Affordable Care Act. J Soc Work Disabil Rehabil. 2014; 13(1-2):31-43. PMC: 4334111. DOI: 10.1080/1536710X.2013.870512. View

17.

Goldman H, Frank R, Burnam M, Huskamp H, Ridgely M, Normand S . Behavioral health insurance parity for federal employees. N Engl J Med. 2006; 354(13):1378-86. DOI: 10.1056/NEJMsa053737. View

18.

Cummings J, Wen H, Ritvo A, Druss B . Health insurance coverage and the receipt of specialty treatment for substance use disorders among U.S. adults. Psychiatr Serv. 2014; 65(8):1070-3. PMC: 4189808. DOI: 10.1176/appi.ps.201300443. View

19.

Mojtabai R, Chen L, Kaufmann C, Crum R . Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders. J Subst Abuse Treat. 2013; 46(2):268-73. PMC: 3840086. DOI: 10.1016/j.jsat.2013.07.012. View

20.

Stewart M, Horgan C, Hodgkin D, Creedon T, Quinn A, Garito L . Behavioral Health Coverage Under the Affordable Care Act: What Can We Learn From Marketplace Products?. Psychiatr Serv. 2017; 69(3):315-321. PMC: 5832546. DOI: 10.1176/appi.ps.201700098. View